Genomind Press

Genomind Microsite Wins “Best In Class” Award

CHALFONT, PA – March 18, 2013 – Genomind, a personalized medicine company, was awarded “Best in Class” for their Genecept™ Assay microsite,, during the 2013 annual Interactive Media Awards.

The “Best in Class” award is the highest honor awarded in the competition and represents the very best in planning, execution, and overall professionalism. During a comprehensive judging process, sites are reviewed for their design, content, functionality, usability, and browser compatibility. The Genecept Assay microsite won high marks in all categories, including a perfect 100 in functionality.

The Interactive Media Awards are sponsored by the Interactive Media Council, Inc. (IMC), a national nonprofit organization of leading web designers, developers, programmers, advertisers, and other web-related professionals. The annual competition is designed to elevate the standards of excellence in web design, and honor and promote those companies utilizing today’s technology to most effectively share their story.

“Genomind is proud to receive this recognition, but especially pleased to know we have a strong tool to clearly communicate our mission, products, and positive influence to clinicians and patients,” said Scott Storrer, CEO. “The more clinicians know about the Genecept Assay, the more they will use it to help patients suffering from psychiatric disorders receive more effective treatment strategies”.

About Genomind

Genomind is a personalized medicine company, comprised of innovative researchers and expert leaders in psychiatry and neurology. Genomind is committed to discovery of the underlying causes of neuropsychiatric disorders and supports the development of personalized medicine that improves patients’ lives. Genomind was founded by Ronald I. Dozoretz, MD, a psychiatrist who has devoted his career to improving mental health. Jay Lombard, DO, a neurologist and co-founder of Genomind, is a critically acclaimed author and nationally recognized thought leader in neuropsychiatry practice and research.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.